FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:1512244}.
FT   CHAIN         2    758       Microtubule-associated protein tau.
FT                                /FTId=PRO_0000072739.
FT   REPEAT      561    591       Tau/MAP 1.
FT   REPEAT      592    622       Tau/MAP 2.
FT   REPEAT      623    653       Tau/MAP 3.
FT   REPEAT      654    685       Tau/MAP 4.
FT   SITE         24     24       Not glycated.
FT   SITE         44     44       Not glycated.
FT   SITE         67     67       Not glycated.
FT   SITE        381    381       Not glycated.
FT   SITE        391    391       Not glycated.
FT   SITE        392    392       Not glycated.
FT   SITE        394    394       Not glycated.
FT   SITE        465    465       Not glycated.
FT   SITE        497    497       Not glycated.
FT   SITE        507    507       Not glycated.
FT   SITE        541    541       Not glycated.
FT   SITE        557    557       Not glycated.
FT   SITE        571    571       Not glycated.
FT   SITE        574    574       Not glycated.
FT   SITE        584    584       Not glycated.
FT   SITE        591    591       Not glycated.
FT   SITE        607    607       Not glycated.
FT   SITE        611    611       Not glycated.
FT   SITE        615    615       Not glycated.
FT   SITE        628    628       Not glycated.
FT   SITE        634    634       Not glycated.
FT   SITE        638    638       Not glycated.
FT   SITE        648    648       Not glycated.
FT   SITE        657    657       Not glycated.
FT   SITE        660    660       Not glycated.
FT   SITE        687    687       Not glycated.
FT   SITE        692    692       Not glycated.
FT   SITE        700    700       Not glycated.
FT   SITE        702    702       Not glycated.
FT   SITE        712    712       Not glycated.
FT   SITE        755    755       Not glycated.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000269|PubMed:1512244}.
FT   MOD_RES      18     18       Phosphotyrosine; by FYN.
FT                                {ECO:0000269|PubMed:14999081}.
FT   MOD_RES      46     46       Phosphoserine; by PDPK1.
FT   MOD_RES      50     50       Phosphothreonine; by PDPK1.
FT   MOD_RES     214    214       Phosphoserine; by SGK1.
FT                                {ECO:0000269|PubMed:16982696}.
FT   MOD_RES     396    396       Phosphoserine; in PHF-tau.
FT                                {ECO:0000269|PubMed:1899488}.
FT   MOD_RES     470    470       Phosphothreonine; by PDPK1.
FT                                {ECO:0000269|PubMed:9614189}.
FT   MOD_RES     484    484       Deamidated asparagine; in tau and PHF-
FT                                tau; partial.
FT   MOD_RES     492    492       Phosphothreonine; by PDPK1.
FT   MOD_RES     498    498       Phosphothreonine; by PDPK1.
FT                                {ECO:0000269|PubMed:15546861}.
FT   MOD_RES     514    514       Phosphotyrosine; by TTBK1.
FT                                {ECO:0000269|PubMed:16923168}.
FT   MOD_RES     515    515       Phosphoserine; by PDPK1 and TTBK1.
FT                                {ECO:0000269|PubMed:16923168}.
FT   MOD_RES     516    516       Phosphoserine; by PDPK1 and TTBK1.
FT                                {ECO:0000269|PubMed:15546861,
FT                                ECO:0000269|PubMed:16923168,
FT                                ECO:0000269|PubMed:19451179,
FT                                ECO:0000269|PubMed:9614189}.
FT   MOD_RES     519    519       Phosphoserine; by CK1, PDPK1 and TTBK1.
FT                                {ECO:0000269|PubMed:14761950,
FT                                ECO:0000269|PubMed:15546861,
FT                                ECO:0000269|PubMed:16923168,
FT                                ECO:0000269|PubMed:18220336,
FT                                ECO:0000269|PubMed:19451179,
FT                                ECO:0000269|PubMed:21327254,
FT                                ECO:0000269|PubMed:9614189}.
FT   MOD_RES     522    522       Phosphothreonine; by CK1 and PDPK1.
FT                                {ECO:0000269|PubMed:14761950,
FT                                ECO:0000269|PubMed:15546861,
FT                                ECO:0000269|PubMed:19451179}.
FT   MOD_RES     529    529       Phosphothreonine; by BRSK1, BRSK2, DYRK2
FT                                and PDPK1. {ECO:0000269|PubMed:15546861,
FT                                ECO:0000269|PubMed:18599021,
FT                                ECO:0000269|PubMed:19451179,
FT                                ECO:0000269|PubMed:21985311,
FT                                ECO:0000269|PubMed:9614189}.
FT   MOD_RES     531    531       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:15546861,
FT                                ECO:0000269|PubMed:16443603,
FT                                ECO:0000269|PubMed:19451179,
FT                                ECO:0000269|PubMed:9614189}.
FT   MOD_RES     534    534       Phosphothreonine; by PDPK1.
FT                                {ECO:0000269|PubMed:16443603,
FT                                ECO:0000269|PubMed:19451179}.
FT   MOD_RES     548    548       Phosphothreonine; by GSK3-beta and PDPK1.
FT                                {ECO:0000269|PubMed:14690523,
FT                                ECO:0000269|PubMed:15546861,
FT                                ECO:0000269|PubMed:16443603}.
FT   MOD_RES     552    552       Phosphoserine; by PDPK1.
FT                                {ECO:0000269|PubMed:15546861,
FT                                ECO:0000269|PubMed:16443603,
FT                                ECO:0000269|PubMed:9614189}.
FT   MOD_RES     554    554       Phosphoserine; by PHK.
FT                                {ECO:0000269|PubMed:16443603,
FT                                ECO:0000269|PubMed:8999860}.
FT   MOD_RES     579    579       Phosphoserine; by MARK1, BRSK1, BRSK2 and
FT                                PHK. {ECO:0000269|PubMed:15546861,
FT                                ECO:0000269|PubMed:16443603,
FT                                ECO:0000269|PubMed:19451179,
FT                                ECO:0000269|PubMed:21985311,
FT                                ECO:0000269|PubMed:7706316,
FT                                ECO:0000269|PubMed:8999860,
FT                                ECO:0000269|PubMed:9614189}.
FT   MOD_RES     596    596       Deamidated asparagine; in tau and PHF-
FT                                tau; partial.
FT   MOD_RES     602    602       Phosphoserine; by PHK.
FT                                {ECO:0000269|PubMed:8999860}.
FT   MOD_RES     606    606       Phosphoserine; by PHK.
FT                                {ECO:0000269|PubMed:8999860}.
FT   MOD_RES     610    610       Phosphoserine; by MARK1; in PHF-tau.
FT                                {ECO:0000269|PubMed:7706316}.
FT   MOD_RES     622    622       Phosphoserine; by MARK1; in PHF-tau.
FT                                {ECO:0000269|PubMed:7706316}.
FT   MOD_RES     641    641       Phosphoserine; by MARK1; in PHF-tau.
FT                                {ECO:0000269|PubMed:7706316}.
FT   MOD_RES     669    669       Phosphoserine; by PHK.
FT                                {ECO:0000269|PubMed:8999860}.
FT   MOD_RES     673    673       Phosphoserine; by MARK1; in PHF-tau.
FT                                {ECO:0000269|PubMed:7706316}.
FT   MOD_RES     713    713       Phosphoserine; by CK1 and PDPK1.
FT                                {ECO:0000269|PubMed:14761950,
FT                                ECO:0000269|PubMed:15546861,
FT                                ECO:0000269|PubMed:16443603,
FT                                ECO:0000269|PubMed:19451179,
FT                                ECO:0000269|PubMed:19690332,
FT                                ECO:0000269|PubMed:21327254,
FT                                ECO:0000269|PubMed:9614189}.
FT   MOD_RES     717    717       Phosphoserine; alternate.
FT                                {ECO:0000269|PubMed:19690332,
FT                                ECO:0000269|PubMed:21327254}.
FT   MOD_RES     720    720       Phosphothreonine.
FT   MOD_RES     721    721       Phosphoserine; by CK1 and PDPK1.
FT                                {ECO:0000269|PubMed:14761950,
FT                                ECO:0000269|PubMed:15546861,
FT                                ECO:0000269|PubMed:19451179,
FT                                ECO:0000269|PubMed:19690332,
FT                                ECO:0000269|PubMed:21327254,
FT                                ECO:0000269|PubMed:9614189}.
FT   MOD_RES     726    726       Phosphoserine.
FT                                {ECO:0000269|PubMed:15546861,
FT                                ECO:0000269|PubMed:19690332}.
FT   MOD_RES     733    733       Phosphoserine; by CaMK2 and TTBK1.
FT                                {ECO:0000269|PubMed:16923168}.
FT   MOD_RES     739    739       Phosphoserine; by PDPK1 and TTBK1.
FT                                {ECO:0000269|PubMed:16443603,
FT                                ECO:0000269|PubMed:16923168,
FT                                ECO:0000269|PubMed:19451179,
FT                                ECO:0000269|PubMed:9614189}.
FT   MOD_RES     744    744       Phosphothreonine; by TTBK1.
FT                                {ECO:0000269|PubMed:16923168}.
FT   CARBOHYD     87     87       N-linked (Glc) (glycation); in PHF-tau;
FT                                in vitro. {ECO:0000269|PubMed:19451179}.
FT   CARBOHYD    383    383       N-linked (Glc) (glycation); in PHF-tau;
FT                                in vitro. {ECO:0000269|PubMed:19451179}.
FT   CARBOHYD    467    467       N-linked (Glc) (glycation); in PHF-tau;
FT                                in vitro. {ECO:0000269|PubMed:19451179}.
FT   CARBOHYD    480    480       N-linked (Glc) (glycation); in PHF-tau;
FT                                in vitro. {ECO:0000269|PubMed:19451179}.
FT   CARBOHYD    491    491       N-linked (Glc) (glycation); in PHF-tau;
FT                                in vitro. {ECO:0000269|PubMed:19451179}.
FT   CARBOHYD    525    525       O-linked (GlcNAc).
FT                                {ECO:0000269|PubMed:19451179,
FT                                ECO:0000269|PubMed:21327254}.
FT   CARBOHYD    542    542       N-linked (Glc) (glycation); in PHF-tau;
FT                                in vitro. {ECO:0000269|PubMed:19451179}.
FT   CARBOHYD    551    551       N-linked (Glc) (glycation); in PHF-tau;
FT                                in vitro. {ECO:0000269|PubMed:19451179}.
FT   CARBOHYD    555    555       O-linked (GlcNAc).
FT                                {ECO:0000269|PubMed:19451179,
FT                                ECO:0000269|PubMed:21327254}.
FT   CARBOHYD    576    576       N-linked (Glc) (glycation); in PHF-tau;
FT                                in vitro. {ECO:0000269|PubMed:19451179}.
FT   CARBOHYD    597    597       N-linked (Glc) (glycation); in PHF-tau;
FT                                in vitro. {ECO:0000269|PubMed:19451179}.
FT   CARBOHYD    598    598       N-linked (Glc) (glycation); in PHF-tau;
FT                                in vitro. {ECO:0000269|PubMed:19451179}.
FT   CARBOHYD    664    664       N-linked (Glc) (glycation); in PHF-tau;
FT                                in vitro. {ECO:0000269|PubMed:19451179}.
FT   CARBOHYD    670    670       N-linked (Glc) (glycation); in PHF-tau;
FT                                in vitro. {ECO:0000269|PubMed:19451179}.
FT   CARBOHYD    686    686       N-linked (Glc) (glycation); in PHF-tau;
FT                                in vitro. {ECO:0000269|PubMed:19451179}.
FT   CARBOHYD    717    717       O-linked (GlcNAc); alternate.
FT                                {ECO:0000269|PubMed:19451179,
FT                                ECO:0000269|PubMed:21327254}.
FT   DISULFID    608    639       {ECO:0000250}.
FT   CROSSLNK    571    571       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin); in
FT                                PHF-tau. {ECO:0000269|PubMed:15953362,
FT                                ECO:0000269|PubMed:16443603}.
FT   CROSSLNK    628    628       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin); in
FT                                PHF-tau. {ECO:0000269|PubMed:15953362,
FT                                ECO:0000269|PubMed:16443603}.
FT   CROSSLNK    670    670       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin); in
FT                                PHF-tau. {ECO:0000269|PubMed:15953362,
FT                                ECO:0000269|PubMed:16443603}.
FT   VAR_SEQ       1     44       MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDA
FT                                GLK -> MLRALQQRKR (in isoform Tau-A).
FT                                {ECO:0000303|PubMed:2516729}.
FT                                /FTId=VSP_003175.
FT   VAR_SEQ      45     73       Missing (in isoform Tau-A, isoform Tau-D
FT                                and isoform Fetal-tau).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:2498079,
FT                                ECO:0000303|PubMed:2516729,
FT                                ECO:0000303|PubMed:3131773,
FT                                ECO:0000303|Ref.7}.
FT                                /FTId=VSP_003176.
FT   VAR_SEQ      74    102       Missing (in isoform Tau-A, isoform Tau-B,
FT                                isoform Tau-D, isoform Tau-E and isoform
FT                                Fetal-tau). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:2484340,
FT                                ECO:0000303|PubMed:2498079,
FT                                ECO:0000303|PubMed:2516729,
FT                                ECO:0000303|PubMed:3131773,
FT                                ECO:0000303|Ref.6, ECO:0000303|Ref.7}.
FT                                /FTId=VSP_003177.
FT   VAR_SEQ     103    104       Missing (in isoform Tau-A).
FT                                {ECO:0000303|PubMed:2516729}.
FT                                /FTId=VSP_003178.
FT   VAR_SEQ     125    375       Missing (in isoform Tau-A, isoform Tau-B,
FT                                isoform Tau-C, isoform Tau-D, isoform
FT                                Tau-E, isoform Tau-F and isoform Fetal-
FT                                tau). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:2484340,
FT                                ECO:0000303|PubMed:2498079,
FT                                ECO:0000303|PubMed:2516729,
FT                                ECO:0000303|PubMed:3131773,
FT                                ECO:0000303|Ref.6, ECO:0000303|Ref.7}.
FT                                /FTId=VSP_003179.
FT   VAR_SEQ     395    460       Missing (in isoform Tau-A, isoform Tau-B,
FT                                isoform Tau-C, isoform Tau-D, isoform
FT                                Tau-E, isoform Tau-F and isoform Fetal-
FT                                tau). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:2484340,
FT                                ECO:0000303|PubMed:2498079,
FT                                ECO:0000303|PubMed:2516729,
FT                                ECO:0000303|PubMed:3131773,
FT                                ECO:0000303|Ref.6, ECO:0000303|Ref.7}.
FT                                /FTId=VSP_003180.
FT   VAR_SEQ     502    502       S -> SATKQVQRRPPPAGPRSER (in isoform Tau-
FT                                G). {ECO:0000305}.
FT                                /FTId=VSP_026780.
FT   VAR_SEQ     592    622       Missing (in isoform Tau-A, isoform Tau-B,
FT                                isoform Tau-C and isoform Fetal-tau).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:2484340,
FT                                ECO:0000303|PubMed:2516729,
FT                                ECO:0000303|PubMed:3131773,
FT                                ECO:0000303|Ref.7}.
FT                                /FTId=VSP_003181.
FT   VARIANT       5      5       R -> H (in FTD; reduces the ability of
FT                                tau to promote microtubule assembly and
FT                                promotes fibril formation in vitro;
FT                                dbSNP:rs63750959).
FT                                {ECO:0000269|PubMed:11921059}.
FT                                /FTId=VAR_019660.
FT   VARIANT       5      5       R -> L (in PSNP1; delays assembly
FT                                initiation and lowers the mass of
FT                                microtubules formed; but the assembly
FT                                rate is increased compared to normal tau;
FT                                dbSNP:rs63750959).
FT                                {ECO:0000269|PubMed:12325083}.
FT                                /FTId=VAR_019661.
FT   VARIANT      17     17       T -> M (in dbSNP:rs144611688).
FT                                {ECO:0000269|PubMed:20020531}.
FT                                /FTId=VAR_064622.
FT   VARIANT      30     30       T -> A. {ECO:0000269|PubMed:20020531}.
FT                                /FTId=VAR_064623.
FT   VARIANT     285    285       D -> N (risk factor for PSNP1;
FT                                dbSNP:rs62063786).
FT                                {ECO:0000269|PubMed:10534245,
FT                                ECO:0000269|PubMed:9629852}.
FT                                /FTId=VAR_010340.
FT   VARIANT     289    289       V -> A (risk factor for PSNP1;
FT                                dbSNP:rs62063787).
FT                                {ECO:0000269|PubMed:10534245,
FT                                ECO:0000269|PubMed:9629852}.
FT                                /FTId=VAR_010341.
FT   VARIANT     370    370       R -> W (in dbSNP:rs17651549).
FT                                /FTId=VAR_056121.
FT   VARIANT     441    441       Y -> H (in dbSNP:rs2258689).
FT                                {ECO:0000269|PubMed:1420178,
FT                                ECO:0000269|PubMed:15365985,
FT                                ECO:0000269|PubMed:9629852}.
FT                                /FTId=VAR_010342.
FT   VARIANT     447    447       S -> P (in dbSNP:rs10445337).
FT                                {ECO:0000269|PubMed:9629852}.
FT                                /FTId=VAR_010343.
FT   VARIANT     574    574       K -> T (in PIDB; reduces the ability to
FT                                promote microtubule assembly by 70%).
FT                                {ECO:0000269|PubMed:11089577,
FT                                ECO:0000269|PubMed:11117542}.
FT                                /FTId=VAR_010344.
FT   VARIANT     583    583       L -> V (in FTD; less able to promote
FT                                microtubule assembly than wild-type tau).
FT                                {ECO:0000269|PubMed:12509859}.
FT                                /FTId=VAR_019662.
FT   VARIANT     589    589       G -> V (in FTD).
FT                                {ECO:0000269|PubMed:9641683,
FT                                ECO:0000269|PubMed:9973279}.
FT                                /FTId=VAR_010345.
FT   VARIANT     596    596       N -> K (in FTD; with parkinsonism).
FT                                {ECO:0000269|PubMed:10412802,
FT                                ECO:0000269|PubMed:10489057,
FT                                ECO:0000269|PubMed:10802785,
FT                                ECO:0000269|PubMed:12473774,
FT                                ECO:0000269|PubMed:9789048}.
FT                                /FTId=VAR_010346.
FT   VARIANT     597    597       Missing (in FTD).
FT                                {ECO:0000269|PubMed:9973279}.
FT                                /FTId=VAR_010347.
FT   VARIANT     613    613       N -> H (in FTD; reduced the ability of
FT                                tau to promote microtubule assembly
FT                                without having a significant effect on
FT                                tau filament formation; effects at both
FT                                the RNA and the protein level).
FT                                {ECO:0000269|PubMed:11585254}.
FT                                /FTId=VAR_019663.
FT   VARIANT     613    613       Missing (in PSNP1/atypical PSNP1;
FT                                heterozygosity may be a risk factor for
FT                                both a PSNP1-like syndrome and Parkinson
FT                                disease; reduced the ability of tau to
FT                                promote microtubule assembly without
FT                                having a significant effect on tau
FT                                filament formation; effects at both the
FT                                RNA and the protein level).
FT                                {ECO:0000269|PubMed:11220749,
FT                                ECO:0000269|PubMed:14991828,
FT                                ECO:0000269|PubMed:14991829}.
FT                                /FTId=VAR_019664.
FT   VARIANT     617    617       V -> I (in dbSNP:rs116733906).
FT                                {ECO:0000269|PubMed:20020531}.
FT                                /FTId=VAR_064624.
FT   VARIANT     618    618       P -> L (in FTD; most common mutation;
FT                                reduction in the ability to promote
FT                                microtubule assembly; accelerates
FT                                aggregation of tau into filaments).
FT                                {ECO:0000269|PubMed:10214944,
FT                                ECO:0000269|PubMed:9641683,
FT                                ECO:0000269|PubMed:9736786,
FT                                ECO:0000269|PubMed:9789048,
FT                                ECO:0000269|PubMed:9973279}.
FT                                /FTId=VAR_010348.
FT   VARIANT     618    618       P -> S (in FTD and CBD; reduction in the
FT                                ability to promote microtubule assembly).
FT                                {ECO:0000269|PubMed:10374757,
FT                                ECO:0000269|PubMed:10553987,
FT                                ECO:0000269|PubMed:11071507,
FT                                ECO:0000269|PubMed:16240366}.
FT                                /FTId=VAR_010349.
FT   VARIANT     620    620       G -> V (in PSNP1).
FT                                {ECO:0000269|PubMed:16157753}.
FT                                /FTId=VAR_037439.
FT   VARIANT     622    622       S -> N (in FTD; minimal parkinsonism;
FT                                very early age of onset).
FT                                {ECO:0000269|PubMed:10208578}.
FT                                /FTId=VAR_010350.
FT   VARIANT     634    634       K -> M (in FTD).
FT                                {ECO:0000269|PubMed:15883319}.
FT                                /FTId=VAR_037440.
FT   VARIANT     637    637       S -> F (in PIDB; markedly reduced ability
FT                                of tau to promote microtubule assembly).
FT                                {ECO:0000269|PubMed:11891833}.
FT                                /FTId=VAR_019665.
FT   VARIANT     654    654       V -> M (in FTD; ultrastructural and
FT                                biochemical characteristics
FT                                indistinguishable from Alzheimer disease;
FT                                accelerates aggregation of tau into
FT                                filaments). {ECO:0000269|PubMed:10214944,
FT                                ECO:0000269|PubMed:9629852}.
FT                                /FTId=VAR_010351.
FT   VARIANT     659    659       E -> V (in FTD).
FT                                {ECO:0000269|PubMed:11117541}.
FT                                /FTId=VAR_019666.
FT   VARIANT     669    669       S -> L (in fatal respiratory
FT                                hypoventilation; unusual apparent
FT                                autosomal recessive inheritance; reduced
FT                                binding to microtubules as well as
FT                                increased fibrillization and
FT                                aggregation).
FT                                {ECO:0000269|PubMed:14595660}.
FT                                /FTId=VAR_019667.
FT   VARIANT     686    686       K -> I (in PIDB; 90% reduction in the
FT                                rate of microtubule assembly).
FT                                {ECO:0000269|PubMed:11601501}.
FT                                /FTId=VAR_019668.
FT   VARIANT     706    706       G -> R (in PIDB; in vitro the mutation
FT                                reduces the ability of tau to promote
FT                                microtubule assembly by 25 to 30%).
FT                                {ECO:0000269|PubMed:10604746,
FT                                ECO:0000269|PubMed:11117542}.
FT                                /FTId=VAR_010352.
FT   VARIANT     723    723       R -> W (in FTD/Alzheimer disease;
FT                                accelerates aggregation of tau into
FT                                filaments; reduces tau phosphorylation in
FT                                cells compared to both the wild-type and
FT                                other mutant forms).
FT                                {ECO:0000269|PubMed:10214944,
FT                                ECO:0000269|PubMed:11889249,
FT                                ECO:0000269|PubMed:14517953,
FT                                ECO:0000269|PubMed:9641683,
FT                                ECO:0000269|PubMed:9973279}.
FT                                /FTId=VAR_010353.
FT   MUTAGEN     515    515       S->E: No association with plasma
FT                                membrane.
FT   MUTAGEN     516    516       S->E: No association with plasma
FT                                membrane.
FT   MUTAGEN     519    519       S->E: No association with plasma
FT                                membrane.
FT   MUTAGEN     531    531       S->A: No decrease in microtubule-binding
FT                                and nucleation activity after in vitro
FT                                phosphorylation of mutant protein.
FT   MUTAGEN     548    548       T->A: 50% Decrease in microtubule-binding
FT                                after in vitro phosphorylation of mutant
FT                                protein.
FT   MUTAGEN     548    548       T->E: No association with plasma
FT                                membrane.
FT   MUTAGEN     552    552       S->A: 70% decrease in microtubule-binding
FT                                after in vitro phosphorylation of mutant
FT                                protein.
FT   MUTAGEN     552    552       S->E: No association with plasma
FT                                membrane.
FT   MUTAGEN     579    579       S->A: 8% decrease in microtubule-binding
FT                                after in vitro phosphorylation of mutant
FT                                protein.
FT   MUTAGEN     713    713       S->E: No association with plasma
FT                                membrane.
FT   MUTAGEN     721    721       S->E: No association with plasma
FT                                membrane.
FT   MUTAGEN     726    726       S->E: No association with plasma
FT                                membrane.
FT   MUTAGEN     730    730       S->E: No association with plasma
FT                                membrane.
FT   MUTAGEN     739    739       S->E: No association with plasma
FT                                membrane.
FT   CONFLICT     48     48       L -> P (in Ref. 6; AAU45390).
FT                                {ECO:0000305}.
FT   CONFLICT    414    414       H -> L (in Ref. 5; AAC04277).
FT                                {ECO:0000305}.
FT   CONFLICT    557    557       K -> M (in Ref. 12; AAS17881).
FT                                {ECO:0000305}.
FT   CONFLICT    591    591       K -> S (in Ref. 12; AAS17881).
FT                                {ECO:0000305}.
FT   CONFLICT    617    617       V -> Q (in Ref. 17; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    622    622       S -> K (in Ref. 17; AA sequence).
FT                                {ECO:0000305}.
